Hi Hottod,
I went back through your very informative posts until the 30/4. At that time you mentioned 3 additional indications for phase II trials that Rohan had mentioned.
Acute ischaemic optic atrophy, Leber and Glaucoma. It seems like the first has dropped off the list. Maybe it’s hard to do trials on an acute event? Any thoughts? Do you have any information regarding this indication similar to Lebers and Glaucoma or if it’s not mentioned is it likely it’s not on the list of potential trials any more.
Also apologies to counterfiat. I managed to get the ****** site working and listened to the interview. I went back and reread your post and I see you were looking for twelve trials not 8.
- Forums
- ASX - By Stock
- PYC
- Ann: Commencement of RP11 Multiple Dose Trial
Ann: Commencement of RP11 Multiple Dose Trial, page-34
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $933.2M |
Open | High | Low | Value | Volume |
20.5¢ | 20.5¢ | 19.5¢ | $456.8K | 2.282M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 347837 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 103041 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 347837 | 0.195 |
7 | 174478 | 0.190 |
2 | 29000 | 0.185 |
7 | 245546 | 0.180 |
13 | 375426 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 103041 | 1 |
0.205 | 1062851 | 6 |
0.210 | 1111317 | 6 |
0.215 | 1340250 | 6 |
0.220 | 1018500 | 4 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online